Calls for standstill period from creditors to allow new management team time to develop and implement recovery plan 

Commits to transparent and effective communications with the Group’s financial creditors 

Abu Dhabi: One week into his new role as Executive Chairman of the UAE’s largest private healthcare provider NMC Health Plc, Faisal Belhoul today set out his commitments to the company, its healthcare workforce and their patients, and its shareholders and creditors. 

Helping NMC achieve operational and financial stability to provide vital medical services in the nation’s fight against COVID-19 

Belhoul underscored NMC’s critical role in the provision of healthcare in the UAE, which makes the continuance of operations a national priority, particularly as the country and the world battle the COVID-19 pandemic.

The executive chairman stated his immediate priority was to achieve operational and financial stability to provide frontline care in the battle against COVID-19, and to prioritise payments to its healthcare workers and critical suppliers. As the largest private healthcare company in the UAE, the group operates more than 200 facilities including 14 centres of excellence, has more than 2,200 hospital beds and a staff of 2,000 doctors in 20 countries. The NMC Group is currently treating hundreds of people suspected of having COVID-19 and in the UAE has screened more than 10,000 workers for the virus in partnership with the Ministry of Health and Prevention and the Ministry of Human Resources and Emiratisation. The screening programme will include 90 staff testing as many as 200,000 labourers across the Northern Emirates. 

Belhoul stated that under its new leadership, NMC Health plc has the ability and commitment to provide vital healthcare services to the community at this critical time, strengthen the company’s business fundamentals and increase the value of the NMC Group’s business - and consequently returns, to creditors and shareholders.

Belhoul praised the thousands of doctors, nurses and other healthcare professionals at NMC for their continued dedication. “I commit to showing the same levels of support for our team as they show for their patients. The service they provide is invaluable, and their contribution to this country cannot be overstated,” he said. 

New Executive Chairman calls for temporary standstill from creditors to allow time to prepare and activate recovery plan 

Belhoul also called for patience and prudence from his creditors – calling for a temporary standstill to debt repayments to allow the new management team to prepare and activate a recovery plan which would provide greater value for all parties. He also thanked those lenders who had voiced their support for his appointment, adding: “There are considerable downsides to the company and its creditors if we were to be placed into administration. This would cause instability to the operating businesses of the NMC Group, creating additional pressure on the group’s liquidity and reducing value for all creditors.  This would be damaging not only to the interests of creditors but, in the midst of the COVID-19 crisis, would potentially put lives at risk.”

Commitment to transparency, fair payment of creditors and recovery of misused funds 

NMC’s new executive chairman also stated that he fully understood the duties owed to the company’s creditors as the primary economic stakeholders in the NMC Group and vowed that he would do all in his power to cooperate with authorities in the UAE and UK to recover misused funds and ensure those involved in any wrongdoing were prosecuted. “I recognise the position in which the NMC Group finds itself and, as executive chairman, I will be undertaking a review to strengthen governance and control structures and achieve operational stability for the NMC Group as quickly as possible,” said Belhoul. “We are working in full cooperation and in close dialogue with authorities in the UAE and UK, including the UK’s Financial Conduct Authority (FCA), and will vigorously chase down the perpetrators for return of these funds.” 

NMC has committed to treating all creditors equally and not taking actions that prejudice the position of certain creditors relative to others. “Departing from these principles by acceding to the demands of any individual creditor would jeopardise the operating businesses of the NMC Group, increasing the risk of customers and suppliers terminating contracts or re-negotiating terms and putting even more pressure on the group’s liquidity,” said Belhoul. 

To bring independence and transparency to the finance and treasury functions, the board has also appointed PwC to advise on liquidity and operational matters and appointed Moelis as its independent financial advisor to determine the extent of, and assist in the restructuring of, the NMC Group’s debt.

Belhoul’s appointment was made after the company’s non-executive directors uncovered alleged theft and excess undisclosed borrowings by former directors of the company. Belhoul is one of the most highly regarded healthcare business leaders in the region. He is the founder of Ithmar Capital Partners and currently serves as its Chairman and also founded Amanat Holdings PJSC, one of the GCC's largest integrated healthcare and education publicly listed investment companies. In addition, Belhoul was chairman of the board for a number of business groups and associations, including the UAE Private Hospitals Council and the Pharmaceutical and Healthcare Equipment Business Group and was a board member of Al Noor, an FTSE 250 company.

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.